Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sen. Grassley To Be "More Insistent" About Drug Firms' Testimony At Future Hearings

Jan 30 2019

• By Cathy Kelly

Washington DC Capitol dome detail with waving american flag

Related Content

340B Payment Cut Overturned By US Federal Court; What Comes Next?

Jan 04 2019

Biopharma Predicts ‘Significant’ R&D Reductions With Medicare IPI Model

Jan 03 2019

Medicare Part D Payment Model Gives Health Plans More Incentives To Negotiate Lower Drug Prices

Jan 21 2019

Insulin Makers May Be First In Crosshairs Of DeGette Rx Pricing Investigation

Jan 17 2019

Medicare's Foreign Price Bench-marking Will Only Hurt Bad Negotiators, HHS's Azar Argues

Oct 26 2018

Part D Protected Class Management Tools To Save Medicare $1.85bn

Nov 27 2018

Related Companies

Eli Lilly and Company

Additional Topics

United States Pricing Debate Legislation Policy BioPharmaceutical

More from Pricing Debate

More from Market Access

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window